HealthStream, Inc. (HSTM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1155412,
    "name": "HealthStream, Inc.",
    "stock_name": "HealthStream, Inc.",
    "full_name": "HealthStream, Inc.",
    "name_url": "stocks-analysis/healthstream-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "24.71",
    "chg": -0.36,
    "chgp": "-1.44%",
    "dir": -1,
    "prev_price": "25.07",
    "mcapval": "832.62",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Software Products",
    "ind_code": 3310,
    "indexname": "S&P 500",
    "isin": "US42222N1037",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "218.8 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/healthstream-inc-1155412-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is HealthStream, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthstream-inc-overvalued-or-undervalued-3673407",
        "imagepath": "",
        "date": "2025-11-05 11:10:55",
        "description": "As of 31 October 2025, the valuation grade for HealthStream, Inc. has moved from expensive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 46, an EV to EBITDA of 12.29, and a PEG ratio of 6.67, which suggest that while the company is not undervalued, it is also not excessively priced compared to its peers.\n\nIn comparison to its peers, HealthStream, Inc. has a P/E ratio of 40.95, which is lower than the significantly high P/E ratios of Enfusion, Inc. at 260.46 and Cerence, Inc. at 409.37, indicating a more reasonable valuation within the software products industry. However, the company has underperformed against the S&P 500 over multiple periods, with a year-to-date return of -18.14% compared to the S&P 500's 16.30%, which may reflect broader market trends or company-specific challenges...."
      },
      {
        "title": "HealthStream, Inc. Hits New 52-Week Low at $24.07",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/healthstream-inc-hits-new-52-week-low-at-2407-3671482",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/HealthStreamInc_priceRelatedfactors_3671482.png",
        "date": "2025-11-04 17:50:22",
        "description": "HealthStream, Inc. has reached a new 52-week low, reflecting a year-to-date decline while the S&P 500 has gained. The company, with a market cap of approximately USD 833 million, shows modest growth in net sales and operating profit, but has underperformed against broader market indices over the past three years."
      },
      {
        "title": "Is HealthStream, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthstream-inc-overvalued-or-undervalued-3670599",
        "imagepath": "",
        "date": "2025-11-04 11:16:53",
        "description": "As of 31 October 2025, the valuation grade for HealthStream, Inc. moved from expensive to fair. The company appears fairly valued based on its current metrics. Key ratios include a P/E ratio of 46, a Price to Book Value of 2.40, and an EV to EBITDA of 12.29, which suggest that while the company is not undervalued, it is also not excessively priced compared to its peers.\n\nIn comparison to its peers, HealthStream's P/E ratio of 40.95 is significantly lower than Pagaya Technologies Ltd.'s 71.76, indicating a more attractive valuation despite the higher absolute P/E. Couchbase, Inc. shows a negative P/E, further emphasizing HealthStream's relative stability. Although return data is not available, the company's performance can be assessed against the S&P 500, reinforcing the notion that HealthStream is positioned fairly within its market context...."
      },
      {
        "title": "HealthStream, Inc. Experiences Revision in Its Stock Evaluation Amid Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/healthstream-inc-sees-valuation-grade-change-from-expensive-to-fair-amid-stock-fluctuations-3667050",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/HealthStreamInc_valuationdot_3667050.png",
        "date": "2025-11-03 15:41:12",
        "description": "HealthStream, Inc. has recently adjusted its valuation, with a P/E ratio of 46 and a price-to-book value of 2.40. Key metrics include an EV to EBIT ratio of 37.92 and a ROCE of 8.01%. Despite a year-to-date return of -22.64%, the company shows a favorable position compared to peers."
      },
      {
        "title": "Is HealthStream, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthstream-inc-overvalued-or-undervalued-3666169",
        "imagepath": "",
        "date": "2025-11-03 11:16:20",
        "description": "As of 31 October 2025, the valuation grade for HealthStream, Inc. has moved from expensive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 46, an EV to EBITDA of 12.29, and a PEG ratio of 6.67, which indicate that while the company has a high valuation relative to earnings, it is more aligned with its peers compared to some of the riskier options in the market.\n\nIn comparison to its peers, HealthStream's P/E ratio of 40.95 is significantly lower than Pagaya Technologies Ltd.'s 71.76, while Couchbase, Inc. shows a negative P/E, highlighting HealthStream's relatively stable position. Despite the recent underperformance, with a year-to-date return of -22.64% compared to the S&P 500's 16.30%, the long-term 5-year return of 34.43% suggests potential for recovery...."
      },
      {
        "title": "Is HealthStream, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthstream-inc-overvalued-or-undervalued-3664301",
        "imagepath": "",
        "date": "2025-11-02 11:09:18",
        "description": "As of 31 October 2025, the valuation grade for HealthStream, Inc. moved from expensive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 46, an EV to EBITDA of 12.29, and a Price to Book Value of 2.40. In comparison, its peer WalkMe Ltd. has a P/E of -51.68, while Enfusion, Inc. shows a very expensive P/E of 260.46, indicating that HealthStream is positioned more favorably within its competitive landscape.\n\nDespite the fair valuation, HealthStream's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -22.64% compared to the index's gain of 16.30%. This trend highlights potential concerns about the company's growth prospects relative to the broader market...."
      },
      {
        "title": "HealthStream, Inc. Stock Plummets to New 52-Week Low of $24.37",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/healthstream-inc-stock-plummets-to-new-52-week-low-of-2437-3661917",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/HealthStreamInc_priceRelatedfactors_3661917.png",
        "date": "2025-10-31 16:08:26",
        "description": "HealthStream, Inc. has reached a new 52-week low, reflecting a notable decline in its stock price over the past year. The company, with a market cap of USD 833 million, shows a high P/E ratio and has not paid dividends. Despite a slight profit increase, long-term growth remains a challenge."
      },
      {
        "title": "HealthStream, Inc. Stock Plummets to New 52-Week Low of $24.39",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/healthstream-inc-stock-plummets-to-new-52-week-low-of-2439-3659096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/HealthStreamInc_priceRelatedfactors_3659096.png",
        "date": "2025-10-30 18:26:19",
        "description": "HealthStream, Inc. has reached a new 52-week low, reflecting an 11.89% decline in its stock performance over the past year. The company, with a market capitalization of USD 833 million, has a high P/E ratio and has not paid dividends, indicating a conservative financial strategy."
      },
      {
        "title": "Is HealthStream, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthstream-inc-overvalued-or-undervalued-3637733",
        "imagepath": "",
        "date": "2025-10-21 12:07:55",
        "description": "As of 17 October 2025, the valuation grade for HealthStream, Inc. has moved from very attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be overvalued. Key ratios include a P/E ratio of 46, an EV to EBITDA of 12.29, and a Price to Book Value of 2.40, which are relatively high compared to its peers. For instance, Pagaya Technologies Ltd. has a P/E ratio of 71.76, while Couchbase, Inc. shows a negative P/E, highlighting the mixed performance within the sector.\n\nIn terms of performance, HealthStream has underperformed against the S&P 500 over various periods, notably with a year-to-date return of -16.54% compared to the S&P 500's 13.30%. This underperformance, along with its high valuation ratios, suggests that the stock may not be a compelling investment at its current price level...."
      }
    ],
    "total": 22,
    "sid": "1155412",
    "stock_news_url": "https://www.marketsmojo.com/news/healthstream-inc-1155412"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is HealthStream, Inc. overvalued or undervalued?

2025-11-05 11:10:55

As of 31 October 2025, the valuation grade for HealthStream, Inc. has moved from expensive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 46, an EV to EBITDA of 12.29, and a PEG ratio of 6.67, which suggest that while the company is not undervalued, it is also not excessively priced compared to its peers. In comparison to its peers, HealthStream, Inc. has a P/E ratio of 40.95, which is lower than the significantly high P/E ratios of Enfusion, Inc. at 260.46 and Cerence, Inc. at 409.37, indicating a more reasonable valuation within the software products industry. However, the company has underperformed against the S&P 500 over multiple periods, with a year-to-date return of -18.14% compared to the S&P 500's 16.30%, which may reflect broader market trends or company-specific challenges....

HealthStream, Inc. Hits New 52-Week Low at $24.07

2025-11-04 17:50:22

HealthStream, Inc. has reached a new 52-week low, reflecting a year-to-date decline while the S&P 500 has gained. The company, with a market cap of approximately USD 833 million, shows modest growth in net sales and operating profit, but has underperformed against broader market indices over the past three years.

Is HealthStream, Inc. overvalued or undervalued?

2025-11-04 11:16:53

As of 31 October 2025, the valuation grade for HealthStream, Inc. moved from expensive to fair. The company appears fairly valued based on its current metrics. Key ratios include a P/E ratio of 46, a Price to Book Value of 2.40, and an EV to EBITDA of 12.29, which suggest that while the company is not undervalued, it is also not excessively priced compared to its peers. In comparison to its peers, HealthStream's P/E ratio of 40.95 is significantly lower than Pagaya Technologies Ltd.'s 71.76, indicating a more attractive valuation despite the higher absolute P/E. Couchbase, Inc. shows a negative P/E, further emphasizing HealthStream's relative stability. Although return data is not available, the company's performance can be assessed against the S&P 500, reinforcing the notion that HealthStream is positioned fairly within its market context....

HealthStream, Inc. Experiences Revision in Its Stock Evaluation Amid Market Fluctuations

2025-11-03 15:41:12

HealthStream, Inc. has recently adjusted its valuation, with a P/E ratio of 46 and a price-to-book value of 2.40. Key metrics include an EV to EBIT ratio of 37.92 and a ROCE of 8.01%. Despite a year-to-date return of -22.64%, the company shows a favorable position compared to peers.

Is HealthStream, Inc. overvalued or undervalued?

2025-11-03 11:16:20

As of 31 October 2025, the valuation grade for HealthStream, Inc. has moved from expensive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 46, an EV to EBITDA of 12.29, and a PEG ratio of 6.67, which indicate that while the company has a high valuation relative to earnings, it is more aligned with its peers compared to some of the riskier options in the market. In comparison to its peers, HealthStream's P/E ratio of 40.95 is significantly lower than Pagaya Technologies Ltd.'s 71.76, while Couchbase, Inc. shows a negative P/E, highlighting HealthStream's relatively stable position. Despite the recent underperformance, with a year-to-date return of -22.64% compared to the S&P 500's 16.30%, the long-term 5-year return of 34.43% suggests potential for recovery....

Is HealthStream, Inc. overvalued or undervalued?

2025-11-02 11:09:18

As of 31 October 2025, the valuation grade for HealthStream, Inc. moved from expensive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 46, an EV to EBITDA of 12.29, and a Price to Book Value of 2.40. In comparison, its peer WalkMe Ltd. has a P/E of -51.68, while Enfusion, Inc. shows a very expensive P/E of 260.46, indicating that HealthStream is positioned more favorably within its competitive landscape. Despite the fair valuation, HealthStream's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -22.64% compared to the index's gain of 16.30%. This trend highlights potential concerns about the company's growth prospects relative to the broader market....

HealthStream, Inc. Stock Plummets to New 52-Week Low of $24.37

2025-10-31 16:08:26

HealthStream, Inc. has reached a new 52-week low, reflecting a notable decline in its stock price over the past year. The company, with a market cap of USD 833 million, shows a high P/E ratio and has not paid dividends. Despite a slight profit increase, long-term growth remains a challenge.

HealthStream, Inc. Stock Plummets to New 52-Week Low of $24.39

2025-10-30 18:26:19

HealthStream, Inc. has reached a new 52-week low, reflecting an 11.89% decline in its stock performance over the past year. The company, with a market capitalization of USD 833 million, has a high P/E ratio and has not paid dividends, indicating a conservative financial strategy.

Is HealthStream, Inc. overvalued or undervalued?

2025-10-21 12:07:55

As of 17 October 2025, the valuation grade for HealthStream, Inc. has moved from very attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be overvalued. Key ratios include a P/E ratio of 46, an EV to EBITDA of 12.29, and a Price to Book Value of 2.40, which are relatively high compared to its peers. For instance, Pagaya Technologies Ltd. has a P/E ratio of 71.76, while Couchbase, Inc. shows a negative P/E, highlighting the mixed performance within the sector. In terms of performance, HealthStream has underperformed against the S&P 500 over various periods, notably with a year-to-date return of -16.54% compared to the S&P 500's 13.30%. This underperformance, along with its high valuation ratios, suggests that the stock may not be a compelling investment at its current price level....

View All News